Evidence map›Paper›PMID 25411249›Full record

ArticleThe Journal of biological chemistry2015

CDK1-dependent inhibition of the E3 ubiquitin ligase CRL4CDT2 ensures robust transition from S Phase to Mitosis.

Lindsay F Rizzardi, Kate E Coleman, Dileep Varma, Jacob P Matson, Seeun Oh, Jeanette Gowen Cook

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. CRL4Genes · 2022
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. S-phase Specific Downregulation of Human ONeoplasia (New York, N.Y.) · 2018
    Article
  15. Article
  16. Article
  17. Review
  18. Regulation of Mammalian DNA Replication via the Ubiquitin-Proteasome System.Advances in experimental medicine and biology · 2017
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Lindsay F RizzardiFrom the Curriculum in Genetics and Molecular Biology and.
Kate E ColemanFrom the Curriculum in Genetics and Molecular Biology and.
Dileep Varmathe Department of Biochemistry and Biophysics, University of North Carolina, Chapel Hill, North Carolina 27599.
Jacob P Matsonthe Department of Biochemistry and Biophysics, University of North Carolina, Chapel Hill, North Carolina 27599.
Seeun Ohthe Department of Biochemistry and Biophysics, University of North Carolina, Chapel Hill, North Carolina 27599.
Jeanette Gowen CookFrom the Curriculum in Genetics and Molecular Biology and the Department of Biochemistry and Biophysics, University of North Carolina, Chapel Hill, North Carolina 27599 jgcook@email.unc.edu.
University of North Carolina at Chapel Hill · US

Funding

Virology Research Program (Program 4)P30CA016086 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI David Darr · 1985 to 2026
$201.5M
NRSA IN GENETICST32GM007092 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI SEKELSKY, JEFF J. · 1985 to 2019
$5.9M
Post-Translational Regulation of DNA Replication Origin Licensing in Human CellsR01GM102413 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI COOK, JEANETTE GOWEN · 2013 to 2021
$2.5M
Role of the Ndc80 Loop Domain and Cdt1 in Kinetochore Microtubule AttachmentsR00CA178188 · NCI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI VARMA, DILEEP · 2015 to 2017
$660k
Breast Cancer Cell Dormancy is Orchestrated by Stroma & Tissue MicroenvironmentK99CA178177 · NCI · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI BUSSARD, KAREN MARIE · 2013 to 2014
$188k
Linking DNA Replication Origin Licensing with Cell Cycle ProgressionF31CA165891 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI COLEMAN, KATE E · 2013 to 2015
$85k
NCI NIH HHS F31 CA165891NCI NIH HHS F31CA165891NCI NIH HHS K99 CA178177NCI NIH HHS K99CA178177NCI NIH HHS P30 CA016086NCI NIH HHS P30CA016086NIGMS NIH HHS R01 GM102413NIGMS NIH HHS R01GM102413A
6 · The paper itself

Abstract

Replication-coupled destruction of a cohort of cell cycle proteins ensures efficient and precise genome duplication. Three proteins destroyed during replication via the CRL4(CDT2) ubiquitin E3 ligase, CDT1, p21, and SET8 (PR-SET7), are also essential or important during mitosis, making their reaccumulation after S phase a critical cell cycle event. During early and mid-S phase and during DNA repair, proliferating cell nuclear antigen (PCNA) loading onto DNA (PCNA(DNA)) triggers the interaction between CRL4(CDT2) and its substrates, resulting in their degradation. We have discovered that, beginning in late S phase, PCNA(DNA) is no longer sufficient to trigger CRL4(CDT2)-mediated degradation. A CDK1-dependent mechanism that blocks CRL4(CDT2) activity by interfering with CDT2 recruitment to chromatin actively protects CRL4(CDT2) substrates. We postulate that deliberate override of replication-coupled destruction allows anticipatory accumulation in late S phase. We further show that (as for CDT1) de novo SET8 reaccumulation is important for normal mitotic progression. In this manner, CDK1-dependent CRL4(CDT2) inactivation contributes to efficient transition from S phase to mitosis.

Indexed as

MitosisS PhaseCDC2 Protein KinaseCell Cycle ProteinsChromatinCyclin-Dependent Kinase Inhibitor p21Cyclin-Dependent KinasesGene Expression RegulationHCT116 CellsHEK293 CellsHeLa CellsHistone-Lysine N-MethyltransferaseHumansNuclear ProteinsProliferating Cell Nuclear AntigenProteolysisCDC2 Protein KinaseCDK1 protein, humanCDT1 protein, humanCell Cycle ProteinsChromatinCyclin-Dependent Kinase Inhibitor p21Cyclin-Dependent KinasesDTL protein, humanHistone-Lysine N-MethyltransferaseKMT5A protein, humanNuclear ProteinsProliferating Cell Nuclear AntigenUbiquitin-Protein LigasesCDT1CDT2Cell CycleCyclin-dependent Kinase (CDK)DNA ReplicationE3 Ubiquitin LigaseMitosisp21PCNASET8

Identifiers

PMID25411249
PMCPMC4281756
OpenAlexW2013057597

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.